Tumor-derived IL-6 impaired the differentiation of myeloid cells and promoted the accumulation of e-MDSCs by inhibiting SOCS3 expression and persistently activating the JAK/STAT signaling pathway. This evidence concerns the gene SOCS3 and neoplasm.